US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Nektar Therapeutics (ITH0) 銘柄情報

Nektar Therapeutics (ITH0)

55.84

1.34

(2.46%)

終了 6月29日 5:00AM

Nektar Therapeutics (ITH0) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

55.84

( 2.46% )

買値

55.56

売値

56.14

出来高

587

53.42 日の範囲 55.48

18.20 52 週間の範囲 91.40

時価総額

前日終値

54.50

始値

55.48

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,024,085 €

発行済株式数

33,786,032

配当利回り

PER

-8.01

1 株当たり利益 (EPS)

-8.09

歳入

55.63M

純利益

-158.1M

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorder... Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.nektar.com

本社

San Francisco, United States

設立

1990

Nektar Therapeutics is listed in the sector of the Tradegate (DE) with ticker ITH0. The last closing price for Nektar Therapeutics was 54.50 €. Over the last year, Nektar Therapeutics shares have traded in a share price range of 18.20 € to 91.40 €.

Nektar Therapeutics currently has 33,786,032 shares in issue. The market capitalisation of Nektar Therapeutics is 1.89 € billion. Nektar Therapeutics has a price to earnings ratio (PE ratio) of -8.01.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.72	1.30624092888	55.12	59.7	53.42	2913	57.44849355	DE
4	0.96	1.74927113703	54.88	59.7	47.44	1922	53.09623768	DE
12	-7.82	-12.2840087967	63.66	91.4	47.44	1221	61.34391786	DE
26	19.44	53.4065934066	36.4	91.4	28.4	1850	50.24693521	DE
52	30.79	122.914171657	25.05	91.4	18.2	1577	45.28512919	DE
156	45.748	453.30955212	10.092	91.4	7.24	1889	40.77151694	DE
260	45.748	453.30955212	10.092	91.4	7.24	1889	40.77151694	DE

ITH0 - Frequently Asked Questions (FAQ)

What is the current Nektar Therapeutics share price?

The current share price of Nektar Therapeutics is 55.84 €

How many Nektar Therapeutics shares are in issue?

Nektar Therapeutics has 33,786,032 shares in issue

What is the market cap of Nektar Therapeutics?

The market capitalisation of Nektar Therapeutics is EUR 1.89B

What is the 1 year trading range for Nektar Therapeutics share price?

Nektar Therapeutics has traded in the range of 18.20 € to 91.40 € during the past year

What is the PE ratio of Nektar Therapeutics?

The price to earnings ratio of Nektar Therapeutics is -8.01

What is the cash to sales ratio of Nektar Therapeutics?

The cash to sales ratio of Nektar Therapeutics is 39.38

What is the registered address of Nektar Therapeutics?

The registered address for Nektar Therapeutics is 455 Mission Bay Boulevard South, San Francisco, California, 94158

What is the Nektar Therapeutics website address?

The website address for Nektar Therapeutics is www.nektar.com

Crypttolit

Crypttolit 2分前

Hello, good evening beautiful people, Heres a Tip to 5x times you're money ASAP!!! BUY CXAI https://pennystockstobuynow.com/cxapp-cxai-stock-analysis

lakers17

lakers17 3分前

Don't really want him either. Can't hit a free throw and he's no Shaq.

Crypttolit

Crypttolit 3分前

Hello, good evening beautiful people, Heres a Tip to 5x times you're money ASAP!!! BUY CXAI https://pennystockstobuynow.com/cxapp-cxai-stock-analysis

Crypttolit

Crypttolit 4分前

Hi good evening beautiful people, Heres a Tip to 5x times you're money ASAP!!! BUY CXAI https://pennystockstobuynow.com/cxapp-cxai-stock-analysis

Crypttolit

Crypttolit 4分前

Hi good evening people, Heres a Tip to 5x times you're money ASAP!!! BUY CXAI https://pennystockstobuynow.com/cxapp-cxai-stock-analysis

jcromeenes

jcromeenes 5分前

Johnson to send housing bill to Trump on Monday - https://www.yahoo.com/news/politics/articles/johnson-send-housing-bill-trump-183420743.html

EarningsCentral

EarningsCentral 5分前

Crypttolit

Crypttolit 5分前

Heres a Tip to 5x times you're money ASAP!!! BUY $CXAI https://pennystockstobuynow.com/cxapp-cxai-stock-analysis

doc2016

doc2016 7分前

https://finance.yahoo.com/techquantnology/ai/articles/ionq-ionq-launches-clavis-xg-220818037.html

quantum security and pqcd ip released.........fits with the presents quantum initiative.

rocketeer357

rocketeer357 7分前

Sadly I think you're right. Stearns ain't going nowhere. At least not this year.
In Cohen's defence, LA has known nothing but success since plucking Friedman from Tampa. And while Stearns made some bad moves in Milwaukee, the Crew was always competitive under his guidance. And the staff work

Brysh

Nice, thanks for sharing their email response.

Francis Tai is the guy on the far right in the photo from the Sydney expo I posted earlier (his badge is visible)

watcher777

watcher777 11分前

gfp927z

gfp927z 12分前

>>> How Taco Bell beats McDonald's with just 8 ingredients

Helter Skelter

Helter Skelter 16分前

You could be right, Win, on the $20 not sure about the $50. When we hit 12+ in AHs that day I thought my $20 was too low. We have 2 earnings' reports before Christmas. Jun Jul Aug should come out around Sep 25? Sep Oct Nov should come out right before Christmas! Come on $BB give your valued sharehol

ColdDarkHole

ColdDarkHole 16分前

Im sure nobody would know anything until the news release drops. That would be the 2nd one for me. That would effectively make it impossible for me to ever get my money back lmao.

knrorrel

knrorrel 20分前

WebSlinger

WebSlinger 20分前

April 07, 2012 - “It is just the pessimism I have developed after getting my butt handed to me time and time again. Over the past thirty years , I have lost plenty of money on small companies. These companies, to me, seemed like a sure thing. They had wonderful products and were about to "begin pr

JTORENCE

JTORENCE 20分前

Baxers Pay no attention to this guy. He has been around here for years, never getting it right, shooting from the hip. He will not respond . Just a minor league pumper with nothing to back up his predictions
Another wanna be who wants to get not

ihorchu

ihorchu 21分前

Start checking out moving companies for your zip code change! 💵💵💵

MightyX

MightyX 23分前

This is the worst case scenario for shorts

MightyX

MightyX 23分前

Shorts will have-to-cover during share-buy-demand with no dilution bailout.

GS1

BLQpay token volume 740M

https://dex.zeusx.io/info/v3/apollo/tokens/0x884a61883218f176b6f413404229cb5afdb0e722?chain=zeus

gmac8625

gmac8625 27分前

This is a good post. Likely could be some of the reason for the on again off again we have seen. Perhaps they figured it would resolve quicker? Doubt they can influence any decision without raising flags. The governments lawyer didn’t seem like he was really trying. Maybe they are waiting on th rul

hyperopia

hyperopia 28分前

Sorry, I mistyped the year of the first quarter report. It was released on May 15th, 2026, so there hasn't been a press release since. It should have said:
"During the first three months of 2026 the Company continued its progress on multiple fronts, including the following."

Nektar Therapeutics

Exchange Trading Funds

iNAV Xtrackers MSCI Worl...

Euronext Eurozone 60 PAB...

Mirum Pharmaceuticals

Synchrony Financiall

Ardagh Metal Packaging

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。